Notification of cessation of securities - RAC
Released
Released
Announcement PDF
Appendix 3H - Notification of cessation of securities
Announcement Summary
Entity name
RACE ONCOLOGY LTD
Announcement Type
New announcement
Date of this announcement
Tuesday June 03, 2025
Details of +securities that have ceased
ASX +security
code
RACAS
Security description
OPTION EXPIRING
01-NOV-2028 EX $1.95
Number of
+securities that
have ceased
558,040
The +securities have
ceased due to
Date of
cessation
Lapse of conditional right to
securities because the
conditions have not been, or
have become incapable of
being, satisfied
02/06/2025
Refer to next page for full details of the announcement
Appendix 3H - Notification of cessation of securities
1/5
Appendix 3H - Notification of cessation of securities
Part 1 - Announcement Details
1.1 Name of +Entity
RACE ONCOLOGY LTD
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type
Registration Number
ACN
149318749
1.3 ASX issuer code
RAC
1.4 The announcement is
New announcement
1.5 Date of this announcement
3/6/2025
Appendix 3H - Notification of cessation of securities
2/5
Appendix 3H - Notification of cessation of securities
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
RACAS : OPTION EXPIRING 01-NOV-2028 EX $1.95
Unquoted +equity securities that have ceased
Number of securities that have ceased
558,040
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being,
satisfied
Date of cessation
2/6/2025
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
Appendix 3H - Notification of cessation of securities
3/5
Appendix 3H - Notification of cessation of securities
Part 3 - Issued capital following changes
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will
comprise:
The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if
other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description
RAC : ORDINARY FULLY PAID
Total number of
+securities on issue
173,733,549
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
RACAN : OPTION EXPIRING 03-DEC-2026 EX $4.77
112,490
RACAAB : OPTION EXPIRING 30-JUN-2028 EX $2.11
1,251,738
RACAI : OPTION EXPIRING 29-NOV-2025 EX $2.65
4,000,000
RACAS : OPTION EXPIRING 01-NOV-2028 EX $1.95
0
RACAT : OPTION EXPIRING 01-NOV-2028 EX $2.23
489,408
RACAAC : OPTION EXPIRING 25-NOV-2028 EX $2.05
58,446
RACAV : OPTION EXPIRING 31-JAN-2028 EX $2.92
166,450
RACAW : OPTION EXPIRING 24-OCT-2028 EX $1.32
308,247
RACAO : OPTION EXPIRING 22-JUN-2027 EX $2.46
132,000
RACAP : OPTION EXPIRING 15-AUG-2027 EX $3.17
111,000
RACAAA : OPTION EXPIRING 29-MAY-2026 EX $1.25
19,850,955
RACAM : OPTION EXPIRING 01-JUL-2026 EX $4.90
222,219
RACAX : OPTION EXPIRING 29-NOV-2028 EX $1.45
1,534,712
RACAY : OPTION EXPIRING 29-NOV-2028 EX $4.25
3,061,101
Appendix 3H - Notification of cessation of securities
4/5
Appendix 3H - Notification of cessation of securities
RACAZ : OPTION EXPIRING 01-DEC-2028 EX $1.39
440,019
RACAL : OPTION EXPIRING 12-JUL-2026 EX $4.76
270,000
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by
ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in
ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class
of +security in Part 2 of this form.
Appendix 3H - Notification of cessation of securities
5/5
Share your feedback
Discover